Incannex Healthcare IXHL
NASDAQ IXHL
$3.62 +0.18 (+5.23%)
As of: Aug 20, 2026 · 3:59 PM EDT

Incannex Healthcare (IXHL) Liabilities and Shareholders Equity (2020 - 2026)

Incannex Healthcare (IXHL) posted Liabilities and Shareholders Equity of $80.3 million for Q1 2026, up 7.04% sequentially from $75.0 million in Q4 2025, and up 395.67% YoY from $16.2 million in Q1 2025.

Incannex Healthcare (IXHL) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Incannex Healthcare has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $80.3 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 395.67% year-over-year to $80.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $254.5 million (up 321.3% YoY) and the FY2025 annual result came in at $20.4 million, up 19.94% from the prior year.
  • Liabilities and Shareholders Equity advanced to $80.3 million in Q1 2026 per IXHL's latest filing, from $75.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $95.2 million in Q4 2022 and troughed at $11.1 million in Q4 2024.
  • A 5-year average of $39.3 million and a median of $22.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity sank 76.52% in 2023, then soared 575.36% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $95.2 million in 2022, then tumbled by 76.52% to $22.4 million in 2023, then plunged by 50.33% to $11.1 million in 2024, then jumped by 575.36% to $75.0 million in 2025, then rose by 7.04% to $80.3 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $80.3 million, $75.0 million, and $78.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 6.18 Bn
10 Incannex Healthcare 43.22 Mn 43.22 Mn - 80.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.28 Mn
Dec 31, 2025 75.01 Mn
Sep 30, 2025 78.72 Mn
Jun 30, 2025 20.45 Mn
Mar 31, 2025 16.20 Mn
Dec 31, 2024 11.11 Mn
Sep 30, 2024 16.05 Mn
Jun 30, 2024 17.05 Mn
Mar 31, 2024 17.25 Mn
Dec 31, 2023 22.36 Mn
Jun 30, 2023 23.78 Mn
Dec 31, 2022 95.22 Mn
Jun 30, 2022 37.88 Mn
Jun 30, 2021 9.33 Mn
Jun 30, 2020 4.24 Mn